Makani Science develops a breathing sensor that continuously monitors pulmonary function in patients. This technology provides real-time data to healthcare providers, enabling timely interventions for respiratory issues.
Funding
$125K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Continuous monitoring of pulmonary function is challenging, especially outside of clinical settings. Traditional methods often require bulky equipment and trained personnel, limiting accessibility and hindering timely detection of respiratory issues. This can lead to delayed interventions and poorer outcomes for patients with chronic respiratory conditions.
Solution
Makani Science is developing a novel, wearable sensor designed for continuous, real-time monitoring of pulmonary function. This technology aims to provide healthcare providers with comprehensive data on a patient's respiratory status, enabling proactive interventions and personalized treatment plans. The sensor is intended to be non-invasive and easy to use, facilitating remote monitoring and improving patient compliance. By continuously tracking key respiratory parameters, the device can potentially detect early warning signs of deterioration and prevent acute exacerbations. The collected data can be integrated into existing healthcare systems, providing clinicians with a holistic view of their patients' respiratory health.
Target Audience
The primary target audience includes healthcare providers, pulmonologists, respiratory therapists, and patients with chronic respiratory conditions such as asthma, COPD, and cystic fibrosis.
Features
- Non-invasive, wearable sensor for continuous monitoring of pulmonary function.
- Real-time data transmission to healthcare providers.
- Integration with existing healthcare systems and electronic health records (EHRs).
- Remote monitoring capabilities for improved patient compliance.
- Early detection of respiratory deterioration and potential exacerbations.